Polybutadiene

19.04.2023 • News

Versalis Expands Elastomers at Ravenna

Versalis is planning a project at its site in Ravenna, Italy, to increase capacity for elastomers. Estimated investment costs are put at about $80 million

Top-Feature

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.